USPTO serial 79309164
BIOARCTIC
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jun 7, 2022
- Examiner
- BURKE, JUSTINE N
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with BIOARCTIC?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jessica S. Sachs
Jessica S. Sachs Harness, Dickey & Pierce, PLC5445 Corporate DriveSuite 200Troy, MI 48098Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemical substances, chemical materials, chemical preparations, and non-synthetic elements for use in the manufacture of pharmaceuticals; chemical substances and materials for industrial, scientific and laboratory use, other than for medical or veterinary purposes; biochemical preparations for scientific purposes for use in the manufacture of pharmaceuticals; chemical substances for use in the production of drugs, pharmaceuticals and antibodies; reagents for scientific, laboratory, analysis, research, medical research, testing, inspection, detecting or verification use, other than for medical purposes; reagents for scientific or medical research use for use in the development of antibodies, other than for medical or veterinary purposes; reagents for scientific or medical research use for use in scientific apparatus for chemical or biological analysis; stem cells and reconstituted cells for research or scientific purposes; reconstituted cells for the efficiency and tolerance testing of pharmaceutical products for research or scientific purposes; antibodies and antibodies-based chemicals, for use in industry and science, except for medical or veterinary use; biological preparation for use in cell cultures other than for medical or veterinary use; all of the foregoing for use in the manufacture of pharmaceuticals | ACTIVE | — |
| 005 | Medical and veterinary preparations for the treatment of neurodegenerative disorders; medical and veterinary articles, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; pharmaceutical preparations and substances for the treatment of neurodegenerative disorders; biochemical preparations for medical use for the treatment of neurodegenerative disorders; pharmaceutical preparations and medical preparations for the treatment, prevention and diagnosis of Alzheimer's disease, Parkinson's disease and other neurodegenerative diseases and disorders of the central nervous system; antibodies and antibodies-based pharmaceutical preparations for medical purposes; diagnostic preparations for medical or veterinary purposes; medical therapeutic agents for neurodegenerative disorders; reagents for medical use; diagnostic biochemical biomarker reagents for medical use; diagnostic biomarker reagents for medical purposes; live organs and tissues for surgical implantation purpose; cells for medical use; stem cells for medical purposes; sanitary preparations for medical purposes; dietetic substances, namely, dietetic foods adapted for medical purposes; diagnostic materials, namely, diagnostic kits consisting primarily of probes, buffers, and reagents for use in testing for neurological disorders and central nervous system disorders | ACTIVE | — |
| 010 | Medical and veterinary apparatus and instruments, namely, syringes for medical purposes, syringes for injections, hypodermic syringes; medical imaging apparatus; medical apparatus and devices for the diagnosis and treatment of neurological disorders and central nervous system disorders | ACTIVE | — |
| 042 | Scientific and technological services, namely, scientific research and product development and design, in the field of neurodegenerative disorders; medical and pharmacological research services; medical, pharmaceutical and biotechnological laboratory research services; scientific investigations for medical purposes; medical and scientific services, namely medical and scientific research services in the field of the central nervous system, brain disorders and central nervous system related disorders, diseases and pharmaceuticals; medical and scientific research in the field of neurological and neurodegenerative diseases; conducting clinical trials for others; providing scientific information about the results of clinical trials for pharmaceutical products; biochemical analysis and research; drug discovery services; pharmaceutical products development and evaluation | ACTIVE | — |
| 044 | Human healthcare services; medical services; providing medical information; physical examination services; rental of medical machines and apparatus; providing information relating to the rental of medical machines and apparatus; medical diagnostic testing services; optical imaging for medical diagnostic use being medical imaging services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical testing for diagnostic or treatment purposes | ACTIVE | — |
| 045 | Legal services; licensing of research and development methods; licensing of intellectual property | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by BioArctic AB
- Other trademarks owned by BioArctic AB
- Other trademarks owned by BioArctic AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Other trademarks in Class 045
- Similar marks named BIOARCTIC
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 16, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 16, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Sep 7, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 7, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Jun 7, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| May 17, 2022 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| May 17, 2022 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| May 17, 2022 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| May 17, 2022 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 17, 2022 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Apr 29, 2022 | FIXD | ELECTRONIC RECORD REVIEW COMPLETE | — |
| Apr 1, 2022 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Feb 15, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 15, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 14, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jan 26, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 26, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 26, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 11, 2022 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jan 11, 2022 | ALIE | ASSIGNED TO LIE | — |
| Jan 10, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 10, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 10, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 10, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 10, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 14, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 13, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 13, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jun 11, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jun 11, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jun 8, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jun 7, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 7, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Apr 27, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Apr 23, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Apr 22, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |